DRUG RESIDUE AVOIDANCE by Toillion, Alyssa
1 
 
 
Master of Public Health Field Experience Report 
 
 
 
 
DRUG RESIDUE AVOIDANCE 
 
by 
 
ALYSSA TOILLION 
MPH Candidate 
 
 
 
submitted in partial fulfillment of the requirements for the degree 
 
MASTER OF PUBLIC HEALTH 
 
 
 
Graduate Committee: 
Robert Larson, DVM, PhD 
Mike Sanderson, DVM 
Justin Kastner, PhD 
 
 
 
Field Experience Site: 
Kansas Department of Agriculture 
8/15/16 – 5/1/16 
 
Field Experience Preceptor: 
Tarrie Crnic, DVM, MPH 
 
 
 
KANSAS STATE UNIVERSITY 
Manhattan, Kansas 
 
 
2017 
 
  
2 
 
Copyright 
ALYSSA TOILLION 
2017 
 
 
  
3 
 
Abstract 
Antibiotics are used in food-producing animals to treat, prevent, and control 
diseases caused by harmful bacteria. Administration of antibiotics, anthelmintics, 
pesticides, parasiticides, and other therapeutic chemicals to food-producing animals can 
result in a residue.  A residue is defined by the Food and Drug Administration (FDA) 
Center for Veterinary Medicine (CVM) as any compound or metabolite of a compound 
that is present in edible tissues from food animals because of the use of a compound in 
or on animals. Residues can be from the compound itself, its metabolites, or any other 
substances formed in or on food as a result of the compound's use. Any animal that 
receives any therapy that can result in residues cannot, by law, be sent to slaughter 
until the drug has been reduced to a specified level and deemed safe for human 
consumption. Drug concentrations above this level are illegal and known as violative 
residues. It is the responsibility of the producer to ensure the health, safety, and well-
being of their animals while remaining in compliance with state and federal laws. 
Following labels and abiding by withdrawal times are crucial parts in protecting the food 
supply chain.  
Diseases can have a devastating impact on animal welfare and production. 
Consumers have expressed concern regarding the health impact of drug residues in 
their food. These concerns include: toxicity, allergic or hypersensitivity reactions, 
carcinogenic, mutagenic or teratogenic effects, the potential for the development and 
transfer of antibiotic resistant bacteria, and consumer preference of “antibiotic free” 
products. To avoid these concerns, all drugs should be used according to label 
directions and in a judicious manner.  
Drug residue avoidance begins by working with a veterinarian to put into place 
best management practices or “BMPs” and standard operating procedures or “SOPs” 
for a farm or operation. Following the formation of these BMPs and SOPs, all 
employees and stakeholders must be regularly trained and adherence to the BMPs and 
SOPs must be verified. Reading and following product-label directions, maintaining 
good records, and adopting a quality assurance program, all contribute to maintaining 
the safest food supply chain in the world. The Kansas Department of Agriculture 
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received a grant through the FDA with the goal to prevent violative drug residues in 
animal-derived foods produced in Kansas through educational training and outreach to 
livestock producers. This was accomplished through three communication strategies: 
brochures, PowerPoint slide sets, and online training modules. Specific educational 
materials were created for five different animal production segments: beef cattle, dairy 
cattle, swine, poultry, and small ruminants. Upon completion, these materials will be 
made available on the Kansas Department of Agriculture’s website. 
 
Subject Keywords: Drug; Residue; Public Health; Antibiotics; Food-Safety; Withdrawal 
Time; Toxicology; Meat; Milk; Egg; Animals; Humans; Consumers 
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Chapter 1 - Field Experience Scope of Work 
The Kansas Department of Agriculture (KDA) is an agency devoted to supporting 
the agriculture industry. The agency works on behalf of the entire agriculture sector, 
including farmers, ranchers, food establishments and agribusinesses, to protect both 
animal and human health, ensure a safe food supply, and regulate compliance of state 
laws. The organization is dedicated to promoting awareness of Kansas agriculture by 
providing the public with an accurate and reputable source of information. 
KDA received a grant through the Food and Drug Administration (FDA) with the 
goal to prevent violative drug residues in animal-derived foods produced in Kansas 
through educational training and outreach to livestock producers. This is a cooperative 
agreement between the Kansas Department of Agriculture, Kansas State University 
Research and Extension, the Kansas State Veterinary Diagnostic Laboratory and the 
Beef Cattle Institute. 
The purpose of this project was to create and disseminate educational materials 
with the goal to limit the occurrence of drug residues in animal-derived foods. This was 
accomplished through three communication strategies; brochures, PowerPoint slide 
sets, and online training modules. Specific educational materials were created for five 
different animal production segments: beef cattle, dairy cattle, swine, poultry and small 
ruminants. Upon completion, these materials will be made available on the Kansas 
Department of Agriculture’s website. 
The success of this prevention program will be determined by the number of 
individuals who watch the online training modules, attend presentations where the 
PowerPoint slide sets are used, or contact the organizations involved with questions or 
concerns.  
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Chapter 2 
 Learning Objectives 
I have learned an extensive amount of knowledge regarding the issue of drug 
residues in foods of animal origin and how residues can be prevented and controlled. I 
have also learned about the effects residues have on the industry and regulations 
involved to ensure a safe and secure food supply. Lastly, I learned the best tools and 
communication strategies to educate producers on how to avoid drug residues. 
 Activities Performed 
This project involved creating an outline of questions and specific topics 
regarding drug residues for use within the brochures, PowerPoint slide sets, and online 
training modules. After the content was established, a list of industry experts was 
assembled. Numerous industry professionals, veterinarians, extension agents, and 
livestock producers were contacted and each graciously agreed to provide valuable 
assistance to the project, specific to their area of expertise. Interviews, video footage, 
and species-specific information were acquired from participating individuals. It was my 
responsibility to create, design, and produce the informational brochures, PowerPoint 
slide sets, and online training modules. 
Products Developed 
1. Five species-specific brochures (beef cattle, dairy cattle, swine, poultry, and 
small ruminants). These brochures address some of the issues associated 
with drug residues and strategies to prevent residues in foods of animal 
origin.  
2. Five PowerPoint slide sets (cow/calf, feedlot, dairy, swine, and poultry). 
These PowerPoint slide sets focus on the steps livestock producers can 
implement to prevent drug residues. These slide sets will be used by 
veterinarians, extension agents, and educators. 
3. Five species-specific online training modules (beef cattle, dairy cattle, swine, 
poultry, and small ruminants). The modules primarily focus on ways 
producers can prevent drug residues on their operation. Avoidance strategies 
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such as identifying treated animals, keeping appropriate records, establishing 
and maintaining a valid veterinary-client-patient relationship, and following 
product-label directions were addressed in the modules.  
 
The target audiences for this project are producers involved with treating and/or 
managing food-producing animals and veterinarians needing informative resources for 
client-education about best residue prevention practices.  
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Chapter 3 - Capstone Project / Culminating Experience 
Background 
Outbreaks of plague, disease, and illness have existed for centuries. The search 
for understanding the causes of these diseases has continued for many years. In 
approximately 1550 B.C., Egyptians used honey, lard, and lint for dressing wounds. 
Although, it was unknown at the time, honey contains substantial amounts of hydrogen 
peroxide which can kill bacteria. Many ancient cultures used mold, soil, and plants as 
remedies for illness or infection (“Ancient Times,” n.d.). The Egyptians applied moldy 
bread to wounds and used plant extracts to treat infections. These remedies were 
believed to influence the spirits or the gods responsible for illness and suffering 
(“Ancient Times,” n.d.). It is evident now that mold is a fungus that competes with 
bacteria; many antibiotics today are derived from fungi. 
Explanations for disease causation have changed and evolved over time. Around 
the 1600s, there was the belief of “miasma” which was the idea that disease was 
caused by the presence of “bad air”. This was thought to be due to organic 
decomposition of the Earth, producing gases that caused disease. Following the belief 
of miasma, was the belief of contagion, which attributed the transmission of disease 
between people by means of direct contact. Replacing the previous beliefs of miasma 
and contagion, the germ theory became a widely accepted explanation in the late 19th 
century. This theory hypothesized that specific microscopic organisms are the cause of 
specific diseases. This notion paved the way for finding an effective means to kill 
harmful microbes.  
In 1904 a German physician, Dr. Paul Ehrlich, formed the idea that it could be 
possible to kill specific microbes, such as bacteria, that cause diseases without harming 
the body itself. Dr. Ehrlich believed similarly to a bullet being fired from a gun to hit a 
specific target, there could be a way to specifically target invading microbes. This 
became known as the “magic bullet” concept. Dr. Ehrlich was successful in creating this 
“magic bullet” when he discovered certain chemical dyes colored some bacterial cells 
but not others (“The History of Antibiotics,” n.d.). This lead to his discovery of the first 
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chemotherapeutic agent, Compound 606, responsible for providing an effective 
treatment for the endemic disease, Syphilis (A Brief History, 2010).  
Following Ehrlich’s discovery, penicillin the world’s first antibiotic, was discovered 
by Alexander Fleming. It was nicknamed “the wonder drug” during World War II for its 
highly effective treatment of bacterial infections in war time casualties. Within a few 
years of availability, antibiotics had reduced the rate of death from infections in the 
United States by nearly 80 percent, from 280 to 60 deaths per 100,000 population 
(Spellberg, 2010).  
Following the success of penicillin, other antimicrobial agents have been 
introduced and mass-produced for use not only in human medicine, but for animals as 
well. As time progressed, the cost of antibiotics decreased and they became practical to 
use in commercial livestock production (Bowen & Gustafson, 1997). The use of 
antibiotic therapy has transformed the ability to treat infections in animals and is an 
important tool to enhance animal health, animal well-being, and the economics of 
livestock production. In the past, antibiotic use in animals was not limited exclusively to 
treating disease, but was utilized to improve weight gain and feed efficiency, overcome 
parasitic infections, and for prophylactic purposes when disease risk is increased. Early 
examples of antibiotic use in animals were penicillin to treat bovine mastitis, 
streptomycin added to the diet of chicks to improve growth, and chlortetracycline to 
improve weight gain in chickens and reduce the amount of feed needed to bring broilers 
to market weight (Landers, Cohen, Wittum, & Larson, 2012).   
As the demand for meat has increased and technology has advanced, 
management practices have changed and food-animal production has intensified over 
the past 50 years (NRC, 1999). The number of US farms has decreased, while the 
density of animals on those farms have increased considerably (NRC, 1999). 
Production has become more efficient with a greater quantity of commodities produced 
by fewer animals (NRC, 1999).  The goal of an efficient livestock operation is to raise 
animals or produce a product that will in turn result in a profit. This means that animals 
intended for market are free of disease and injury while gaining weight quickly and 
efficiently. Herd health management plans with detailed disease prevention and 
treatment protocols are instrumental for the success of a producer’s farm or operation. 
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The use of antibiotics on a livestock operation benefits the producer by improved 
productivity, it enhances animal welfare by the effective treatment of sick animals, and it 
addresses consumer demand for a safe, inexpensive food supply. While there are 
strong incentives to appropriately use antibiotics to ensure only healthy animals enter 
the food supply and to enhance efficiency within the industry, the use of antibiotics is 
not without risk. Antibiotic resistance, drug residues, toxicity, and hypersensitivity 
reactions are all concerns that have increased with antibiotic usage. The focus of this 
project revolves around the concern of drug residues, which can affect human health 
through trace amounts of antimicrobial drugs present in meat, milk, or eggs. 
Antibiotic residues in meat, milk, or eggs can occur for a variety of reasons 
including: failure to adhere to proper withdrawal regulations, extra-label use of animal 
drugs, or insufficient animal identification to prevent marketing of animals or animal-
products until the withdrawal time has passed. Although residues found in animal-
derived foods pose a relatively low risk, it is important that livestock producers are 
educated about the practices to avoid these residues. In 2014, the percentage of bulk 
milk tankers that reported a positive result for drug residues was 0.014% and this 
number has been on a consistent decline (Graph 1). This graph signifies a dramatic 
decrease over a 20-year period from an already low-level of occurrence.  
Drug residue avoidance is an important topic to be addressed due to the 
potential risk to consumers and human health concerns. Through increased education 
and proper herd health management this small percentage will continue to decline. It is 
the responsibility of the livestock producer to ensure the health, safety, and well-being 
of their animals while remaining in compliance with state and federal laws. 
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Drug Residue 
A residue is defined by FDA’s Center for Veterinary Medicine (CVM) as any 
compound or metabolite of a compound that is present in edible tissues from food 
animals because of the use of a compound in or on animals. Residues can be from the 
compound itself, its metabolites, or any other substances formed in or on food as a 
result of the compound's use (21 CFR 500.82 (B), n.d.). Residues are not just limited to 
veterinary pharmaceuticals such as antibiotics and de-wormers. Other chemicals, 
insecticides, vaccines, or other products given or applied to food animals can be 
sources of residues. Drug residues refer specifically to veterinary pharmaceutical 
products such as antimicrobials and deworming products (NRC, 1999). 
Any animal that receives any therapy that can result in residues cannot, by law, 
be sent to slaughter until the drug has been reduced to a specified level and deemed 
safe for human consumption. Drug concentrations above this level are illegal causing 
the food to be adulterated and known as a violative residue.  
Graph 1 Percent of Bulk Milk Tankers Positive for Drug Residues 
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Drug Approval Process 
A pivotal point in time for the laws surrounding the drug approval process was 
following the well-known thalidomide incident in Europe. Prior to this incident, the FDA 
did not place any regulations on drug approval or monitoring. 
In 1953, Ciba, a pharmaceutical company based in Switzerland, was the first to 
synthesize thalidomide. This drug was intended to be used as an anticonvulsive agent; 
however, following lab tests the drug did not show the desired effect, so research on 
thaldiomide was stopped. A few years later, in 1957, a West German pharmaceutical 
company re-examined the compound and found it worked as a sleep-aid with no 
apparent side effects. It became a popular sleeping pill and sold under the trade name 
Contergan. It was advertised as being “completely safe” for everyone, including 
pregnant women. Exacerbating the situation, an Australian obstetrician discovered the 
drug also alleviated morning sickness and began recommending off-label use to his 
pregnant patients. In addition to treating morning sickness, thalidomide was often 
combined with aspirin and used to treat just about everything from colds to asthma; 
some claimed it even helped treat loss of vision, diabetes, autoimmune disease, and 
some forms of cancer (Tantibanchachai, 2014). After only three years of being on the 
market, sales were competitive with those of aspirin. It was not long until the side effects 
were unveiled and disaster struck. The drug resulted in phocomelia, which is an 
interference in the development process causing shortened, absent, or flipper-like limbs. 
This devastating event has caused more than 10,000 birth defects worldwide, ultimately 
leading to the rigorous drug approval and monitoring systems in place today by 
the FDA. 
Before the thalidomide incident there were no laws requiring physicians to keep 
records of the drugs they prescribed, nor were the physicians required to follow-up with 
their patients. The pressure of this thalidomide incident compelled Congress to pass in 
1962 the Amendments to the Federal Food, Drug and Cosmetic Act. The 1962 
Amendments stated that the sponsor company had to provide the FDA with a detailed 
outline of the study, monitor the progress of the studies, and continually report its 
findings to the FDA. Before these amendments, the FDA approved an average of 46.2 
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new single drug entities annually. In the decade after, that number dropped to 15.7 
(Tantibanchachai, 2014). 
There is now extensive regulatory oversight to ensure drugs approved for use 
are safe and effective. Extensive toxicology and pharmacology studies are required to 
demonstrate that consumers will not suffer harmful consequences from taking approved 
drugs. The pharmaceutical company applying for drug approval is responsible for 
providing CVM with scientific information and experimental data showing that the 
presence of residues from a compound in edible animal products is safe for consumers 
(NRC, 1999). Following the drug approval process, active surveillance and compliance 
programs are in place to ensure the proper use of antibiotics and the safety of the food 
supply. 
 
Residue Testing 
The United States Department of Agriculture’s Food Safety and Inspection 
Service (USDA FSIS) protects public health by ensuring the supply of meat, poultry, and 
processed egg products are safe, wholesome, and do not contain violative residues 
(USDA FSIS, 2014). The National Residue Program (NRP) is a regulatory program 
administered by FSIS, designed to monitor, detect, reduce, and control violative 
residues in both domestic and imported food products (Muñiz Ortiz & O’Keefe, 2015). 
The NRP collects samples of livestock and poultry tissues at slaughtering 
establishments under its inspection authority and from import shipments at ports of 
entry. The samples are analyzed for the presence of unacceptable residue 
concentrations of animal drugs that might contaminate meat and other tissues (NRC, 
1999). 
This program involves three principal agencies: the Food Safety and Inspection 
Service (FSIS), the Food and Drug Administration (FDA), and the Environmental 
Protection Agency (EPA). The FDA establishes tolerances for veterinary drugs and food 
additives, while the EPA establishes tolerances for registered pesticides. Each year the 
FSIS publishes a modified version of a Residue Sampling Plan known as the Blue Book 
and Residue Sampling Results known as the Red Book. These books outline the 
production classes sampled, the sample size, the drug classes that are tested for and 
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the results. The results indicate how many samples yielded a positive result or a 
violative residue, the production class the positives were found in, and the specific 
drug(s) used. 
To narrow the effort of residue testing, the NRP operates using a three-tiered 
sampling system. Tier 1 is scheduled sampling aimed to collect a set number of random 
samples at the time of slaughter from the following production classes: beef cows, bob 
veal, dairy cows, steer, heifers, market hogs, sows, goats, young chickens, and young 
turkeys. The samples taken in the Tier 1 sampling plan is based on process to 
determine what samples need to be collected. This process begins with determining 
which compounds are a food safety concern. Once that determination has been made, 
algorithms are used to rank the selected compounds. These compounds are then 
compared with the appropriate production class establishing the number of samples that 
need to be collected (“Antibiotic Stewardship,” n.d.). This system allows FSIS to decide 
where available resources and testing efforts should be assigned. 
Prior to 2012, FSIS tested 230 to 300 samples from each production class to 
obtain results that ensured a 90 or 95 percent probability, respectively, of detecting at 
least one residue violation (FSIS, 2017). In 2012, FSIS increased its sample size to 
about 800 samples for each of the nine major production classes tested under Tier 1. 
The number of samples collected is aimed at statistically identifying the occurrence of 
residues. It is based on the probability of detecting at least one violation. The table 
below provides the calculated number of samples required to ensure detection of at 
least one violation. For example, 780 samples are required to detect at least one 
violation with a 98% probability. 
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These sampling results can be used to identify producers most likely to market 
animals with violative levels of residues. Tier 2 samples are inspector-generated 
samples collected from animal carcasses of suspect animals that may contain violative 
residues. Suspect animals are considered high risk for violative residues. This is based 
on criteria such as incidence of past violations or questionable practices detected on the 
farm or processing site (NRC, 1999). Additionally, findings during ante-mortem or post-
mortem inspection such as animals that display lameness, injection site lesions, or 
signs of illness are targeted for testing. Tier 3 is targeted sampling at the herd or flock 
level. A targeted testing program is used to determine the level of chemicals originating 
from the same farm or geographic region certain animals have been exposed to. This 
type of sampling is conducted in response to information obtained by the FDA and EPA 
regarding misuse of antimicrobial agents. 
Despite changes in production practices, a consistent amount of meat is 
produced each year. According to the 2014 Residue Sampling Plan also known as the 
Blue Book, 33 million cattle (bulls, beef cows, dairy cows, heifers, steers, bob veal, 
formula-fed veal, non-formula-fed veal, and heavy calves), 112 million swine (market 
hogs, roaster pigs, boars/stags, and sows) and nearly 9 billion poultry (young chickens, 
mature chickens, young turkeys, mature turkeys, ducks, geese, and other fowl) were 
slaughtered in the U.S. yielding close to 110 billion pounds of meat. The 2015 Blue 
Book does not report these numbers. The 2016 Blue Book reported 29 million cattle, 
Table 1 Samples Required to Detect at Least One Violation 
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112 million swine and nearly 9 billion poultry were slaughtered yielding approximately 
99 billion pounds of meat. Most recently, the 2017 Blue Book reported 30 million cattle, 
117 million swine and nearly 9 billion poultry were slaughtered in the U.S. yielding 
approximately 98 billion pounds of meat (NRP, 2016). These numbers are estimates for 
each production class in which FSIS has regulatory responsibility. In 2014, the amount 
of domestically-produced product consumed relative to the total for all of these 
production classes are 23.287% for cattle, 20.819% for swine, and 51.511% for poultry. 
This stays consistent as the 2016 percentage of product consumed relative to the total 
is 23.251% for cattle, 23.465% for swine, and 46.276% for poultry. Similarly, in 2017, 
25.02% for cattle, 25.09% for swine, and 46.84% for poultry were the estimated 
consumption for each production class. 
Results from the 2014 Red Book show that the tier 1 program collected 6,066 
randomly selected residue samples (Table 2) and found a total of 12 lab-confirmed 
violations (Table 3) or 0.2 percent. Similarly, the 2015 Red Book results showed that 
domestic tier 1 program collected 6,445 samples with 12 violations or 0.2 percent. 
Lastly, the 2016 Red Book results show that domestic tier 1 program collected 7,067 
residue samples and found 26 violations or 0.4 percent. The production classes 
sampled included: bovine (beef cows, bob veal, dairy cows, heifers, and steers); porcine 
(market swine, roaster swine, and sows); poultry (mature turkeys, young chickens, and 
young turkeys); and minor species (goats and sheep). Antimicrobial drugs are the 
majority of violations in scheduled sampling (NRP, 2016). In 2014 and 2015, the bob 
veal slaughter class contained the most residue violations found in Ceftiofur and by the 
multi-residue method (MRM), respectively. The MRM screening method screens for a 
variety of analytes, not just antibiotics, and can distinguish individual analytes even if 
multiple drugs are present in the same sample. In 2016, avermectins in goats was the 
most commonly detected antimicrobial agent, constituting seven of the twenty-six 
residue violations.  
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Table 2 Total Number of Scheduled Samples Analyzed by Slaughter Class (2014) 
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Table 3 Scheduled Sampling Results (2014) 
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A separate inspection effort from the NRP is made to prevent contaminated milk 
from entering the food supply. The Grade “A” Pasteurized Milk Ordinance (PMO) 
established by the FDA, is a set of minimum standards and requirements for regulating 
the production, processing, and packaging of Grade A milk (FARAD, 2017). Although 
jurisdiction is given to individual states, most states adopt the PMO standards as a 
minimum. Milk is tested on the farm, in the bulk tank by the trucker, and at the plant. All 
milk tankers are screened for beta-lactam drug residues while other drug residues are 
screened by using a random-sampling program.  
 
 
 
Table 4 shows the milk residue screening detection tests. The type of test run 
depends on how many samples need to be run, the species, and the sensitivity of the 
test. The Charm SL test takes approximately 8 minutes and is for raw commingled 
cattle, goat, sheep, and water buffalo. The Charm SL3 test takes 3 minutes and is only 
for cattle. Both of the Charm tests feature a test strip and following incubation are 
placed in a reader interpretation machine; a negative number corresponds to a negative 
test result and a positive number corresponds to a positive test result. The Delvotest 
contains 96 wells, allowing for multiple samples to be ran at once. It takes 
approximately two and a half hours, yellow indicates a negative result and purple 
Table 4 Milk Residue Screening Detection Tests 
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indicates a positive result. The Delvotest is for only cattle milk. Lastly, the SNAP test 
takes approximately 10 minutes and is run for cow, camel, or goat milk. The results are 
compared against a control. If the sample spot is lighter than the control then it is 
positive, if the sample spot is darker then it is a negative result. All positive test results 
in any species require a laboratory-confirmed test. 
If a violative residue is detected in food-producing animals at slaughter, FSIS will 
notify the producer and other parties involved. These products are considered 
adulterated and subject to condemnation. Any animal that tests positive for a violative 
residue does not enter into the food supply chain. First time violators will receive a 
notification letter. Repeat violators will be subject to injunction and are included in the 
Residue Repeat Violator List maintained by the FSIS (USDA FSIS, 2014). This list 
contains the names and addresses of producers who have more than one residue 
violation in a 12-month period in animals presented for slaughter (Figure 1). This list is 
updated weekly and intended to aid inspectors in discovering residue tolerance 
violations before they reach consumers. FSIS also maintains a similar list intended to 
precaution livestock marketers when marketing animals from owners or operations on 
the repeat violator list. 
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If the evidence shows blatant misuse, use of unapproved or banned drugs, 
issuing false guarantees, or multiple misdemeanor counts the result will be prosecution. 
FSIS enforces these tolerances through its various control programs authorized by the 
Federal Meat Inspection Act (FMIA), Poultry Products Inspection Act (PPIA), and Egg 
Products Inspection Act (EPIA). 
The tests used by FSIS in the NRP have been improved and are more sensitive 
for detecting chemical and drug residues than prior to 2012. The new multi-class testing 
method allows samples to be simultaneously analyzed for many different drugs, 
reducing the time needed and the need for class-specific confirmation tests. The 
specific detection limit is between 5-500 parts per billion for veterinary drugs and 5-50 
ppb for pesticides. Increasingly sensitive analytical tests are causing the detectable zero 
Figure 1 Residue Repeat Violator List (2017) 
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to become smaller and smaller. The analytical testing methods can now detect parts per 
trillion and parts per billion as opposed to parts per million. There are certain 
substances for which the FDA has established a zero-tolerance policy, meaning there 
must be complete absence of residual amounts; the entire drug that has been 
administered must be completely eliminated. Clenbuterol and Chloramphenicol are 
examples of zero-tolerance drugs. Both drugs are illegal in food-producing animals and 
prohibited from human food entirely, because they pose a significant health risk. Due to 
higher sensitivity tests, these agents are avoided because zero-tolerance is becoming 
harder and harder to achieve. It can be concluded that if these drugs were administered 
to production animals, there will nearly always be detectable residues, but such 
residues would be at an extremely low concentration. 
In summary, in-plant FSIS inspectors collect and analyze samples at the time of 
slaughter for the presence of unacceptable residue concentrations of veterinary drugs 
that might contaminate meat or other tissues (NRP, 2016). If a positive test result is 
obtained, the carcass is held until a laboratory-confirmed test has verified the result. If 
the confirmatory test comes back positive the animal is marked condemned and does 
not enter the food supply. Violations are referred to the FDA for investigation and 
enforcement action. 
 
Human Health Hazards 
Diseases can have a devastating impact on animal welfare and production. 
Animal health affects food-safety and food-safety affects public health. Consumers have 
expressed concern regarding the health impact of drug residues in their food. These 
concerns include: toxicity, allergic or hypersensitivity reactions, carcinogenic, mutagenic 
or teratogenic effects, the potential for the development and transfer of antibiotic 
resistant bacteria, and consumer preference of “antibiotic free” products.  
Depending on the type of adverse effect, some violative levels of drugs in 
products of animal origin pose a greater risk to public health than others. On average, 
the U.S. meat industries produce 100 billion pounds of meat each year. In all the 
samples taken by FSIS each year approximately 0.2 percent are found positive with a 
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violative residue. This shows that while the occurrence of drug residues is minimal, 
there is room for improvement.  
The ingestion of residue via food can cause direct adverse toxic effects such as 
organ damage or tumor development. The term toxicity describes a toxin’s effect in 
terms of potency. It is the amount of a substance that can cause damage to an 
organism. It can refer to the whole organism or a substructure such as the cell 
(cytotoxicity) or an organ such as the liver (hepatoxicity). 
One of the main concerns related to drug residues are allergic or hypersensitivity 
reactions. These reactions result from an overresponse of the immune system to the 
standard dose of a drug (Sylvia, 2014). Penicillin and other beta-lactam antibiotics are 
the most commonly recognized substances that can prompt serious allergic reactions.  
There is also the potential for cancer, reproductive, or developmental related 
effects as well. A carcinogen is any substance capable of causing cancer. A mutagen is 
the potential of a gene mutagen or chromosome breakages as a result of a drug or 
environmental chemical that may affect human fertility (Beyene, 2015). A teratogen 
refers to a drug or chemical agent that produces a toxic effect on the embryo or fetus. 
These are all concerns, but without any known direct foodborne connections. 
The use of antibiotics is the single most important factor leading to antibiotic 
resistance. Resistance involves increasing the prevalence of bacteria that have a 
mechanism to block the inhibitory or killing effects of antibiotics. In human medicine, 
antibiotics are prescribed at an alarmingly high rate and are among the most commonly 
prescribed drugs used in human medicine. However, up to 50% of all the antibiotics 
prescribed for people are not needed or are not optimally effective as prescribed (CDC, 
2013). Antibiotic use in livestock has the potential to create resistant bacteria that is 
then transmitted to humans through food-borne pathogens. Companion animals also 
have the possibility of spreading drug-resistant bacteria to their owners through the 
direct contact they have to humans.  
Some consumers believe products labeled “antibiotic free” are safer and 
healthier than conventionally raised products. In an entirely “antibiotic free” market, 
livestock producers would carry a financial burden of no longer having the tools needed 
to treat sick animals. Under normal circumstances, animals treated for a disease would 
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later be sent to market and sold for a profit. This profit would be returned back to the 
producer. In the scenario of an “antibiotic free” saturated market, any animal in need of 
medical treatment that does not naturally overcome illness would be euthanized and 
therefore would not enter the food supply for human consumption. The money invested 
in those animals would be wasted, making it a financial loss for the producer. The 
number of healthy animals making it to the slaughter facilities would significantly 
decrease. Since the supply would decrease, but the demand would presumably stay the 
same, prices would increase. The inability to use antibiotics when necessary would 
contribute to already existing health disparities, by limiting the access to healthy food, 
for low-income people. These individuals would be unable to purchase products of 
dietary importance such as meat or milk due to the increase in prices. It is important that 
sustainable practices in the industry such as the judicious use of antibiotics are utilized 
to help meet the needs of a growing population and to supply everyone a nutritious and 
inexpensive food source. 
 
Veterinary-Client-Patient Relationship  
Over-the-counter or nonprescription medicine allows for easy access and 
convenience, but fails to provide third-party monitoring of drug use. Whereas 
prescription drugs require oversight by a medical professional. A prescribed medication 
increases the likelihood that a drug is given to the correct patient, for the correct illness, 
and that it is administered properly, and according to label. It is now required by the 
Veterinary Feed Directive that all medically important veterinary drugs are prescribed by 
a veterinarian within the confines of a valid veterinary-client-patient relationship. 
A Veterinary-Client-Patient Relationship or VCPR is a relationship that exists 
when a veterinarian is familiar enough with a livestock operation to be able to take 
responsibility for making clinical judgments regarding animal health. According to the 
American Veterinary Medical Association, a veterinarian in a VCPR makes medical 
judgments, accepts responsibility for providing the herd’s livestock with medical care, 
keeps a written medical record, advises the livestock producer about the benefits and 
risks of different treatment options, provides oversight of treatment and helps to assure 
that emergency care can be provided if the need should arise (VCPR, 2017). The client 
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agrees to maintain records and follow the instructions of the veterinarian. The value of a 
VCPR is critical to the health of an animal. Without an established relationship with a 
veterinarian, livestock producers cannot legally use any drugs in an extra-label manner. 
A valid VCPR can improve animal productivity, enhance animal health and well-being, 
and decrease the risk of drug residues. 
 
Extra-Label Drug Use  
The 1994 Animal Medicinal Drug Use Clarification Act (AMDUCA) enacted by 
Congress provided veterinarians acting within a VCPR the ability to legally prescribe 
medication in an extra-label manner when the health of an animal is threatened or 
suffering and/or death may result from failure to treat (ELDU, 2017). Regulations 
regarding ELDU are covered in the Code of Federal Regulations (CFR) and maintained 
by the FDA which has a list of drugs that are prohibited for ELDU for food-producing 
animals. The following agents are not allowed to be used in an extra-label manner in 
any food-producing species: Chloramphenicol, Clenbuterol, Diethylstilbesterol (DES), 
Fluoroquinolones, Glycopeptides, Medicated feeds, Nitroimidazoles, and Nitrofurans 
(FARAD, n.d.). 
Extra-label drug use or ELDU is the use of an approved drug in a manner that is 
not in accordance with the approved label directions (AMDUCA, 2014). The use of a 
drug in a manner that is different from the label instructions can be in regard to the 
disease being treated, route of administration of the drug, dosage of the drug, or the 
treatment regimen. Any deviation from the label (ELDU) is only permitted under the 
direct guidance and supervision of a licensed veterinarian that has an established 
Veterinary-Client-Patient Relationship (VCPR) with the animal(s) being treated.  
When a veterinarian prescribes extra-label use of a veterinary pharmaceutical, 
the withdrawal time of that drug will change. In order to comply with AMDUCA the 
veterinarian must establish an extended withdrawal time that is supported by scientific 
evidence. The Food Animal Residue Avoidance Databank (FARAD) is a national 
database that serves as a resource to protect our nation’s food supply. This databank 
allows veterinarians to seek expert assistance. FARAD gathers and analyzes scientific 
reports, publications, and other resources in conjunction with kinetic modeling to 
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determine an appropriate revised drug withdrawal time. FARAD offers a searchable 
database of previously determined withdrawal interval recommendations by FARAD for 
drugs used extra‐label called the WDI Lookup. Another feature offered is the ability to 
calculate future withdrawal dates using FARAD’s Withdrawal Date Calculator (WDC). 
Lastly, FARAD offers a searchable database called the Veterinarian’s Guide to Residue 
Avoidance Management (VetGRAM) that provides a comprehensive database of all 
regulatory information (tolerance, withdrawal time, etc.) for all approved drugs in food 
animals. This is a resource for veterinarians to prescribe extra-label with accurate 
adjusted withdrawal times (FARAD, n.d.).  
 
Withdrawal time  
A withdrawal time is established for each specific pharmaceutical product given 
to a food-producing animal with consideration for the safety of the food product 
consumer. During the drug approval process the following are used to calculate an 
established withdrawal time: No observable adverse effect level (NOAEL), acceptable 
daily intake (ADI), safe concentration, and tolerance. 
NOAEL is the level of exposure to the drug at which no adverse effects on an 
animal’s health is detected. Once established, a safety factor is then applied, often 
decreasing the NOAEL by up to a thousand-fold. This safety factor results in a relatively 
large safety margin when used according to label and when withdrawal times are 
followed. The NOAEL is multiplied by the average body weight of a human, resulting in 
the total acceptable daily intake (ADI). This is the average consumption of eggs, milk, or 
other animal tissues a person can ingest throughout the course of their life with no 
adverse effects. This is to ensure long-term consumption of the food product will not 
result in any negative effects. This measurement is known as the safe concentration; it 
is how much of the drug can be in the eggs, milk, or edible tissues. The safe 
concentration applies to all residues including parent compounds and metabolites of the 
chemical or drug.  
The tolerance level uses a portion of the residue called a marker residue. A 
marker residue’s concentration decreases in a known relationship to the level of total 
residues in the eggs, milk, or other animal tissues (“Veterinary Drug Residues”, n.d.). 
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This level depends on the product (thickness of fluid), dosage form (volume of injection), 
route of administration, location of infection, and size of the animal. The tolerance is a 
partial of the total residue and constitutes a percentage. For example, if the safe 
concentration is 0.2 mcg of drug per gram of tissue and the marker residue constitutes 
half of the total residues, the tolerance would become 0.1 mcg/gm for muscle (0.2 X 
50%). To be considered safe for human consumption, drug concentrations in the edible 
tissues must be below the tolerance level. These levels are established during the drug 
approval or pesticide registration process and are listed in the U.S. Code of Federal 
Regulations (Title 21 for veterinary drugs and Title 40 for pesticides) (NRP, 2016). 
Tolerance violations indicate that the amount of residue present exceeds the maximum 
legal limit allowed in food or safe concentration. This happens when an effective 
withdrawal time is not followed. 
Similar to the tolerance level is the maximum residue level (MRL). The MRL is 
not used in the U.S. rather it is an accepted approximation of the tolerance used by 
other countries and by the Codex Alimentarius Commission. Additionally, the CVM uses 
what is known as a safe level. This level is based on available safety data and intended 
to serve as a guide for estimating the safety of residues in meat or milk when no official 
tolerance level exists. Generally, safe levels are assigned only when residues appear in 
meat or milk because of an unapproved use of an animal drug and because a formal 
tolerance level does not exist (NRC, 1999). 
A withdrawal time is the period of time between when a drug is administered and 
when drug concentrations are below the tolerance level. It is the time needed for the 
residue to reach a safe concentration as defined by the tolerance level (Beyene 2015). 
This is when an animal can be slaughtered and it is safe to consume edible products 
from that treated animal. Violations indicate the amount of residue present exceeds the 
maximum legal limit allowed in food or milk. The withdrawal time only applies if the drug 
is used according to label. If a veterinarian authorizes use of a drug in an extra-label 
manner, he/she must also establish an extended withdrawal time. 
The withdrawal time is set in regards to how the drug moves through the animal’s 
body, or pharmacokinetics. The factors that influence this are the rate of absorption 
from the site of administration, the distribution of the drug from the blood out into the 
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tissue, the metabolism of the drug, and the rate of elimination from the blood (Beyene, 
2015). Withdrawal time is based on the concentration of a drug falling below the 
tolerance level in a target animal tissue or organ. The target tissue or organ used to 
determine violative residues are most commonly the muscle, liver, kidney, or fat. These 
tissues are typically eaten in large amounts, function as storage sites, or facilitate the 
process of elimination from the body. As the primary tissue, this is the site where the 
drug is eliminated at the slowest rate and will display a residue for the longest amount of 
time.  
If a violative residue is found in the target organ, the whole carcass is discarded. 
There are drugs that have a muscle tolerance level as opposed to the target organ. If a 
violative residue is found in an organ, but not in the muscle, the muscle would not be 
discarded and it would be deemed safe. 
 
Veterinary Feed Directive  
FDA Guidance’s 209 and 213 revisions came into effect January 1, 2017 making 
it illegal for medically important antibiotics to be used to promote growth in food animals. 
These new standards require a Veterinary Feed Directive (VFD) and veterinary 
oversight when administering certain antibiotics in animal feed. A VFD is a written 
document provided by a licensed veterinarian, which authorizes the use of a VFD drug 
in or on animal feed in accordance with label directions approved by the FDA. This 
requires not only a signed consent form, but a valid VCPR. The purpose of the VFD is 
enhance responsible antibiotic use via increased veterinary oversight. 
 
Prevention Practices 
It is the responsibility of the producer to ensure the health, safety, and well-being 
of their animals while remaining in compliance with state and federal laws. Producers 
can take the following steps to prevent drug residues. Violative residues are often a 
result of human management errors such as failure to maintain records or follow proper 
withdrawal times. Below is a list of drug residue prevention practices: 
 
1. Establish a valid veterinary-client-patient relationship 
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2. Implement a herd health management plan (quarantine, vaccinate, etc.) 
3. Read and follow all label directions (including withdrawal times and proper drug 
administration) 
4. Seek veterinary guidance to establish appropriate extended withdrawal times for 
extra-label usage of approved drugs 
5. Identify treated animals 
6. Keep records that include the identification of the animal(s) treated, treatment 
date, the product used, dosage and who administrated it, and withdrawal time 
7. Train and educate animal caretakers, employees, etc. by providing clear 
instructions and follow-up 
8. Adopt a quality assurance program (proper animal handling, injection site 
techniques, etc.) 
9. Provide proper nutrition  
10. Implement a biosecurity plan (clean feeders, clean manure and bedding, clean 
equipment, supply fresh water, etc.) 
Best management practices or “BMPs” and standard operating procedures or 
“SOPs” are important aspects of disease prevention. All employees and stakeholders 
must be regularly trained and adherence to the BMPs and SOPs must be verified. 
Reading and following product label directions, maintaining good records, and adopting 
a quality assurance program that encompasses a wide array of topics from drug 
storage, administration techniques, and humane animal handling practices, all 
contribute to maintaining the safest food supply chain in the world. 
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Chapter 4 - Core Area Competencies 
The following are core competencies required in Kansas State University’s 
Masters of Public Health program. These courses provided a multi-disciplinary 
approach with a solid foundation of knowledge that is necessary to successfully 
complete a field experience project. 
 
Biostatistics 
MPH 701 Fundamental Methods of Biostatistics, STAT 703 Introduction to 
Statistical Methods for the Sciences, and STAT 705 Regression and Analysis of 
Variance aided in my knowledge of data interpretation and analysis. These courses 
covered descriptive statistics, basic probability theory, hypothesis testing, and linear 
regressions. This knowledge proved to be useful in my literature review and will be 
invaluable in my future career.  
 
Environmental Health Sciences 
MPH 802 Environmental health sciences provided a broad overview of the 
sources of toxicity in the environment and risks and hazards associated with each of 
them. This understanding allowed me to be effective when determining individuals at 
high-risk for negative health consequences due to drug residues. 
 
Epidemiology 
 DMP 708 Introduction to Veterinary Epidemiology and DMP 854 Intermediate 
Epidemiology provided me with the terminology I would need to understand topics 
related to disease, food-safety, and animal/human health. This course taught how to 
quantify disease occurrence and disease transmission, the implications for individual 
and population health management, and how to measure disease frequency and risk 
factors. DMP 854 Intermediate Epidemiology helped me to understand how to draw 
appropriate inferences from epidemiologic data by identifying strengths and limitations 
of a dataset. 
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Health Services Administration 
MPH 720 Administration of Health Care Organizations demonstrated to me the 
importance of understanding the health care system. It provided a comprehensive 
overview of the health care system and how that system responds to economic, 
social/ethical, political/legal, technological, and ecological environments.  
 
Social and Behavioral Sciences 
This core competency course broadened my understanding of factors that 
influence health care. MPH 818 Social and Behavioral Bases of Public Health 
emphasized the relationships among health outcomes, health behaviors, and 
social/political/environmental structures. In order to effectively communicate to the 
public about the importance of drug residue avoidance, it is vital to understand the 
target audience and what influences their opinions, attitudes, and behaviors. MC 750 
Strategic Health Care Communication introduced me to various communication theories 
and the challenges associated in health communication and promotion. It addresses the 
relationship between consumers and health professionals by examining the 
interpersonal, intrapersonal, organizational, and societal-level health communication 
processes.  
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Chapter 5 – Conclusion 
While our nation has the safest food supply chain in the world, there is potential 
for error and room for improvement. Agriculture production practices utilize certain 
compounds that if used incorrectly may pose a public health hazard. The use of 
antibiotics, anthelmintics, pesticides, and other drugs in food-producing species are an 
integral part to the process of raising food animals. Veterinary drugs are used not only 
to treat, control, and prevent disease, but also to benefit animal welfare by helping to 
ensure healthy and well-nourished livestock. Properly administered veterinary drugs can 
also benefit food-safety and public health by improving the health of livestock and 
decreasing the likelihood of a sick animal entering the food supply chain.  
Management errors are often the cause of residues. Regulations are in place that 
if followed should effectively ensure the absence of drug residues. One method to 
address management shortfalls is effective education. Drug residue avoidance 
strategies should be clearly understood by all livestock producers. Residue prevention 
practices are simple and contribute not only to drug residue avoidance but also to 
maintaining a healthy and profitable herd.  
There has been a continuous and coordinated effort between government 
agencies, veterinarians, and livestock producers to protect public health before an 
antibiotic is ever used on an animal. Programs are in place such as the National 
Residue Program, the Pasteurized Milk Ordinance, and the Veterinary Feed Directive to 
regulate the use of antibiotics and monitor drug residues through a rigorous, extensive 
process of sampling, testing, notification, and enforcement.  
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Appendix 1 - Participating Individuals 
 
Dairy 
Hildebrand Dairy – Melissa Reed 
Kansas Department of Agriculture – George Blush 
Kansas Veterinary Diagnostic Laboratory – Dr. Gregg Hanzlieck 
Dairy Farmers of America – Peyson Shields, David Darr and Dr. Fabian Bernal  
Jim Lauderdale 
Food Armor – Dr. Katie MrDutt 
 
Beef 
Cattle Empire - Dr. Dave Sjeklocha 
Beef Producer - Paige Pratt 
Assistant Professor/Extension Beef Veterinarian - Dr. AJ Tarpoff 
American Angus Association – Ryan Ruppert 
 
Poultry 
Associate Professor - Dr. Scott Beyer 
Nutritionist - Jeff May 
Good Shepherd Poultry Ranch, Producer - Frank Reese 
 
Small Ruminants 
Goddard Goat Farm, Producer - Noah Goddard 
Terabithia Goat Farm, Producer - Becky Thorpe 
Veterinarian - Joan Bowen  
Veterinarian - Joan Dean Rowe 
Extension/Field Veterinarian - Patty Scharko 
Kansas State University Sheep & Meat Goat Center 
Ebert Sheep Farm – Jeff Ebert 
 
Exhibition 
Producer - Dale Lanham 
Producer - Brian Creager 
Kansas State Fair - Susan Sankey  
Kansas Livestock Association – Matt Teagarden 
Nebraska State Fair – Bill Angell 
 
Swine 
Professor/Extension Specialist - Dr. Mike Tokach 
Sabetha Vet Clinic - Dr. Jeff DeMint 
Kansas Pork Association - Jodi Oleen 
 
Food and Animal Residue Avoidance Databank (FARAD) 
Dr. Ronette Gehring 
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Merck Animal Health 
Dr. Jason Nickell 
 
Food Inspection and Safety 
Rita Kishore, Dr. Rosemary Turner, Gabrielle Johnston, Patrick Oleary and others 
 
Script editors: Dr. DJ Rezac, Dr. Brian Lubbers, Dr. Kevin DeDonder and Dr. Charley 
Cull 
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Appendix 2 – Species-Specific Brochures 
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Appendix 3 – Power Point Slide Sets 
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